➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Harvard Business School
AstraZeneca
Boehringer Ingelheim
Johnson and Johnson

Last Updated: January 18, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Zidebactam

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Zidebactam?

Zidebactam is an investigational drug.

There have been 4 clinical trials for Zidebactam. The most recent clinical trial was a Phase 1 trial, which was initiated on February 1st 2016.

The most common disease conditions in clinical trials are Renal Insufficiency and [disabled in preview]. The leading clinical trial sponsors are Wockhardt, Quintiles, Inc., and Clinartis.

There are seven US patents protecting this investigational drug and sixty-five international patents.

Recent Clinical Trials for Zidebactam
TitleSponsorPhase
Plasma and Intrapulmonary Concentrations Study of WCK 5222WockhardtPhase 1
To Investigate The Pharmacokinetics Of Intravenous WCK 5222 (FEP-ZID) In Patients With Renal ImpairmentClinartisPhase 1
To Investigate The Pharmacokinetics Of Intravenous WCK 5222 (FEP-ZID) In Patients With Renal ImpairmentWockhardtPhase 1

See all Zidebactam clinical trials

Clinical Trial Summary for Zidebactam

Top disease conditions for Zidebactam
Top clinical trial sponsors for Zidebactam

See all Zidebactam clinical trials

US Patents for Zidebactam

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Zidebactam   Start Trial Pharmaceutical compositions comprising antibacterial agents WOCKHARDT LIMITED (Chikalthana, Aurangabad, IN)   Start Trial
Zidebactam   Start Trial Nitrogen containing compounds Wockhardt Ltd. (Bandra-Kurla Complex, Bandra East, Mumbai, IN)   Start Trial
Zidebactam   Start Trial Compositions and methods for treating bacterial infections WOCKHARDT LIMITED (Chikalthana, IN)   Start Trial
Zidebactam   Start Trial Process for preparation of (2S, 5R)-7-oxo-6-sulphooxy-2[((3R)-piperidine-3-carbonyl)-hydrazino carbonyl]-1,6-diaza-bicyclo [3.2.1]-octane WOCKHARDT LIMITED (Chikalthana, Aurangabad, IN)   Start Trial
Zidebactam   Start Trial Process for preparation of (2S,5R)-6-sulphooxy-7-oxo-2-[((3R)-piperidine-3-carbonyl)-hydrazinocarbon- yl]-1,6-diaza-bicyclo[3.2.1] octane WOCKHARDT LIMITED (Chikalthana, Aurangabad, IN)   Start Trial
Zidebactam   Start Trial Pharmaceutical compositions comprising antibacterial agents WOCKHARDT LIMITED (Chikalthana, Aurangabad, IN)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Zidebactam

Drugname Country Document Number Estimated Expiration Related US Patent
Zidebactam Australia AU2015208830 1989-12-31   Start Trial
Zidebactam Canada CA2954553 1989-12-31   Start Trial
Zidebactam European Patent Office EP3217979 1989-12-31   Start Trial
Zidebactam India IN193MU2014 1989-12-31   Start Trial
Zidebactam Russian Federation RU2017110457 1989-12-31   Start Trial
Zidebactam World Intellectual Property Organization (WIPO) WO2015110950 1989-12-31   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Harvard Business School
AstraZeneca
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.